Several healthcare and biotech stocks posted notable gains in Monday's after-hours trading following earnings updates and guidance revisions.KalVista Pharmaceuticals Inc. (KALV) rose 11.29% to $12.12 after hours, building on a modest 1.02% gain at the close. The company reported a third-quarter net loss of $49.5 million, or $0.92 per share, compared to a loss of $39.1 million, or $0.84 per share, in the same period last year. Net product revenue for the quarter reached $13.7 million.Health Catalyst Inc. (H ...

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]

Health Catalyst (HCAT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +20.00%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post earnings of $0.03 per share when it actually produced earnings of $0.04, delivering a surprise of ...

For the quarter ended September 2025, Health Catalyst (HCAT) reported revenue of $76.32 million, representing no change compared to the same period last year. EPS came in at $0.06, compared to $0.07 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $75.08 million, representing a surprise of +1.66%. The company delivered an EPS surprise of +20%, with the consensus EPS estimate being $0.05.While investors closely watch year-over-year changes in headline numbers -- revenu ...

Health Catalyst (NasdaqGS:HCAT) Q3 2025 Earnings Call November 10, 2025 05:00 PM ET Company ParticipantsMatt Hopper - Senior VP of Finance and Head of Investor RelationsJeff Garro - Managing Director in Healthcare IT Equity ResearchDan Burton - CEOBen Albert - President and COOJason Alger - CFOGabie Ingoglia - Equity Research AssociateRichard Close - Managing Director in Digital and Tech-Enabled Health Equity ResearchJared Haase - Equity Research AssociateElizabeth Anderson - Senior Managing DirectorConfere ...

Health Catalyst (NasdaqGS:HCAT) Q3 2025 Earnings Call November 10, 2025 05:00 PM ET Company ParticipantsMatt Hopper - Senior VP of Finance and Head of Investor RelationsJeff Garro - Managing Director in Healthcare IT Equity ResearchDan Burton - CEOBen Albert - President and COOJason Alger - CFOGabie Ingoglia - Equity Research AssociateRichard Close - Managing Director in Digital and Tech-Enabled Health Equity ResearchJared Haase - Equity Research AssociateElizabeth Anderson - Senior Managing DirectorConfere ...

Health Catalyst (NasdaqGS:HCAT) Q3 2025 Earnings Call November 10, 2025 05:00 PM ET Speaker4Welcome to the Health Catalyst Third Quarter 2025 earnings conference call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions following the presentation. If you would like to ask a question at that time, please press Star 1 on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing Sta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its cha ...

"For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure," said Dan Burton, CEO of Health Catalyst. "By focusing on high-impact solutions with proven ROI and maintaining a commitment to understanding and evolving with our clients, we have reaffirmed our full-year 2025 guidance. We believe our commitment to strategic focus, cost management, and targete ...

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure,” said Dan Burton, C ...